Vident Advisory, LLC Neogenomics Inc Transaction History
Vident Advisory, LLC
- $3.97 Trillion
- Q3 2024
A detailed history of Vident Advisory, LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Vident Advisory, LLC holds 52,441 shares of NEO stock, worth $882,582. This represents 0.02% of its overall portfolio holdings.
Number of Shares
52,441
Previous 50,164
4.54%
Holding current value
$882,582
Previous $696 Million
11.17%
% of portfolio
0.02%
Previous 0.02%
Shares
6 transactions
Others Institutions Holding NEO
# of Institutions
294Shares Held
124MCall Options Held
698KPut Options Held
120K-
Black Rock Inc. New York, NY19.7MShares$331 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14MShares$236 Million0.0% of portfolio
-
Brown Advisory Inc6.89MShares$116 Million0.13% of portfolio
-
Janus Henderson Group PLC London, X06.6MShares$111 Million0.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.54MShares$110 Million0.06% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $2.12B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...